PCI Pharma Services
NDC Database

PCI Pharma Services

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Bulk Ingredient Drug for Further Processing
  • Total Records 4
  • Latest Marketing Date 2026-03-09
  • Data Source FDA
  • First Marketing Date 2015-07-08
All
4
View
Bulk Ingredient
1
View
Drug for Further Processing
3
View
Company Overview

Company

PCI Pharma Services

Country

U.S.A

Website

Visit Website

Email

sales@pciservices.com

Social Profiles

LinkedIn X / Twitter
Company Snapshot

PCI Pharma Services

3001 Red Lion Road Philadelphia, PA, 19114

U.S.A

pciservices.com/ sales@pciservices.com View on Map
NDC Records ( 4 records )
2015
08 Jul
Bulk Ingredient NDC: 73301-003

Nonproprietary Name

Cangrelor

Dosage Form

POWDER

Strength

1 g/g

Labeler

LSNE, Inc

Marketing Category

BULK INGREDIENT

73301-003

Substance

CANGRELOR

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2015-07-08

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
12 Dec
Drug for Further Processing NDC: 73301-009

Nonproprietary Name

rabacfosadine for injection

Dosage Form

INJECTION

Strength

16.4 mg/1.02mL

Labeler

LSNE, Inc

Marketing Category

DRUG FOR FURTHER PROCESSING

73301-009

Substance

RABACFOSADINE SUCCINATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-12-12

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2024
16 Oct
Drug for Further Processing NDC: 73301-016

Nonproprietary Name

Omadacycline

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Strength

100 mg/5mL

Labeler

LSNE, Inc

Marketing Category

DRUG FOR FURTHER PROCESSING

73301-016

Substance

OMADACYCLINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2024-10-16

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2026
09 Mar
Drug for Further Processing NDC: 73301-018

Nonproprietary Name

pegzilarginase-nbln injection

Dosage Form

INJECTION

Strength

2 mg/.4mL

Labeler

LSNE, Inc

Marketing Category

DRUG FOR FURTHER PROCESSING

73301-018

Substance

PEGZILARGINASE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2026-03-09

End Marketing Date

-

Listing Record Certified Through

2027-12-31

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    4 View
  • FDA Approved Drugs Database
    0 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
4 total
  • Bulk Ingredient
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

73301-003

Nonproprietary Name

Cangrelor

Labeler

LSNE, Inc

Dosage Form

POWDER

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit